Tekla Life Sciences Inves...

NYSE: HQL · Real-Time Price · USD
13.82
0.17 (1.25%)
At close: Aug 15, 2025, 3:59 PM
13.86
0.29%
After-hours: Aug 15, 2025, 05:16 PM EDT

Tekla Life Sciences Investors Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Cash & Equivalents
n/a 477.00 445.00 990.00
Short-Term Investments
n/a 15.24M 32.94M 17.17M
Long-Term Investments
460.3M 397.53M 414.08M 534.01M
Other Long-Term Assets
13.9M n/a -414.08M -534.01M
Receivables
231.11K 5.04M 623.47K 150.34K
Inventory
n/a 20.29M 33.57M 17.32M
Other Current Assets
8.97K -20.29M 11.09M 8.46M
Total Current Assets
281.61K 5.05M 623.92K 144.66K
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
474.2M 397.53M 414.08M 534.01M
Total Assets
460.58M 402.6M 414.73M 534.19M
Account Payables
1.79K n/a 5.1M n/a
Deferred Revenue
n/a n/a 5.09M n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
886.82K n/a -5.1M -9.4M
Total Current Liabilities
888.61K n/a 5.1M 10.75M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a -1.34M
Total Long-Term Liabilities
n/a n/a 5.1M 9.4M
Total Liabilities
888.61K 666.96K 16.82M 10.75M
Total Debt
n/a n/a 11.09K 1.34M
Common Stock
280.61K 267.91K 256.8K 246.68K
Retained Earnings
44.13M -1.48M 9.55M 150.7M
Comprehensive Income
n/a n/a -0.00 0.00
Shareholders Equity
459.69M 401.93M 397.9M 523.44M
Total Investments
460.3M 397.53M 414.08M 534.01M